CFIF Joins Coalition Opposing Pelosi Drug Tax Plan |
![]() |
By CFIF Staff
Tuesday, October 15 2019 |
The Center for Individual Freedom (“CFIF”) today joined a coalition letter signed by more than 70 organizations and activists in opposition to House Speaker Nancy Pelosi’s drug pricing proposal (H.R. 3). The letter, addressed to Congress and which was organized by Americans for Tax Reform, is pasted below or can be read here.
October 15, 2019
Dear Members of Congress:
We write in opposition to the prescription drug pricing bill offered by House Speaker Nancy Pelosi that would impose an excise tax of up to a 95 percent on hundreds of prescription medicines.
In addition to this new tax, the bill imposes new government price controls that would decimate innovation and distort supply, leading to the same lack of access to the newest and best drugs for patients in other countries that impose these price controls.
Under Speaker Pelosi’s plan, pharmaceutical manufacturers would face a retroactive tax of up to 95 percent on the total sales of a drug (not net profits). This means that a manufacturer selling a medicine for $100 will owe $95 in tax for every product sold with no allowance for the costs incurred. No deductions would be allowed, and it would be imposed on manufacturers in addition to federal and state income taxes they must pay.
The alternative to paying this tax is for the companies to submit to strict government price controls on the medicines they produce. While the Pelosi bill claims this is “negotiation,” the plan is more akin to theft.
If this tax hike plan were signed into law, it would cripple the ability of manufacturers to operate and develop new medicines.
It is clear that the Pelosi plan does not represent a good faith attempt to lower drug prices. Rather, it is a proposal that would crush the pharmaceutical industry, deter innovation, and dramatically reduce the ability of patients to access life-saving medicines.
We urge you to oppose the Pelosi plan that would impose price controls and a 95 percent medicine tax on the companies that develop and produce these medicines.
Sincerely,
Grover Norquist
James L. Martin
Saulius “Saul” Anuzis
Dick Patten
Phil Kerpen
Daniel Schneider
Steve Pociask
Lisa B. Nelson
Michael Bowman
Dee Stewart
Tom Giovanetti
Norm Singleton
Ryan Ellis
Andrew F. Quinlan
Jeffrey Mazzella
Ginevra Joyce-Myers
Peter J. Pitts
Olivia Grady
Chuck Muth
David McIntosh
Curt Levey
Iain Murray
James Edwards
Matthew Kandrach
Fred Cyrus Roeder
Tom Schatz
Katie McAuliffe
Richard Watson
Adam Brandon
George Landrith
Grace-Marie Turner
Naomi Lopez
The Honorable Frank Lasee
Jessica Anderson
Rodolfo E. Milani
Mario H. Lopez
Carrie Lukas
Heather R. Higgins
Merrill Matthews
Chris Ingstad
Sal Nuzzo
The Honorable Paul R LePage
Seton Motley
Doug McCullough
Mary Adams
Matthew Gagnon
Victoria Bucklin
Charles Sauer
Jameson Taylor, Ph.D.
The Honorable Tim Jones
Brent Mead
Pete Sepp
The Honorable Bill O'Brien
The Honorable Beth A. O’Connor
The Honorable Niraj J. Antani
Douglas Kellogg
Honorable Jeff Kropf
Daniel Erspamer
Lorenzo Montanari
Paul Gessing
James L. Setterlund
Karen Kerrigan
David Miller & Brian Shrive
Tim Andrews
Judson Phillips
David Balat
Sara Croom
Kevin Fuller |
Related Articles : |